Hikma stock heads into the open after a 1.8 percent gain
Published on 09/09/2026 at 04:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hikma stock closed at 1,628 pence on the London Stock Exchange on September 8, 2026, up about 1.8 percent from the previous session.
September 8, 2026 in numbers
Hikma Pharmaceuticals PLC (ISIN GB00B128J450, London Stock Exchange: HIK) finished trading at 1,628 pence on September 8, 2026, after Barclays raised its stance on the shares to equal weight from underweight.Morningstar Alliance News Intraday data for that session showed Hikma among the notable gainers in the FTSE 250, with the stock adding roughly 1.8 percent by the close, while a Barclays sector note reported a gain of about 1.4 percent earlier in European trading.Investing.com Market snapshots around the week indicated that Hikma was trading close to the top of its 52-week range, with a recent reference level of 2,340 pence and a 52-week high of 2,360 pence, leaving only about 20 pence, or 0.8 percent, between the latest higher reference area and that peak.MarketScreener In the same period, the broader London mid-cap segment was more muted, so Hikma’s near-range performance highlighted a comparatively stronger profile than many peers.
Rating impact and near-term outlook today
On September 8, 2026, Barclays published a strategy note on European pharmaceuticals, turning more cautious on the sector into 2027 but upgrading Hikma to equal weight and citing selected stocks it still favors.Barclays research note via Investing.com The upgrade helped lift Hikma’s shares during the session and remains a fresh reference point for investors ahead of today’s trading, as the bank’s more balanced view on the company contrasts with its guarded stance on parts of the wider pharmaceutical universe. In parallel, recent commentary has placed Hikma among generic drug makers positioned for growth opportunities in African markets, adding a broader context to sentiment around the stock without changing the near-term trading calendar.The Star Today, investors can continue to weigh the implications of the Barclays call and sector positioning as London markets open, while monitoring how Hikma trades relative to its tight 52-week band and to the wider FTSE 250 benchmark.
